First in the Middle East: M42’s International Patient Services Receives Global Healthcare Accreditation Certification

M42 Group Facilities in Abu Dhabi Achieve Global Healthcare Accreditation Certification

Abu Dhabi, UAE: M42, a global tech-enabled health powerhouse, has recently been awarded the prestigious Global Healthcare Accreditation (GHA) Certification for Excellence in Medical Travel Patient Experience. This certification recognizes M42’s commitment to providing exceptional care and support to international patients seeking treatment at their facilities, including Cleveland Clinic Abu Dhabi, Healthpoint, and Imperial College London Diabetes Centre.

With an impressive overall score of 91 percent, M42 has proven its dedication to delivering culturally sensitive and compassionate care to patients from all over the world. The International Patient Services (IPS) department at M42 ensures that international patients receive personalized support from assigned Ambassadors, who guide them through every step of their medical journey, from initial contact to departure. By prioritizing critical patient access points, M42 guarantees that their medical travel services not only meet but exceed the expectations of international patients.

M42 has become a leading destination for patients seeking advanced medical procedures, attracting individuals from countries such as the United Kingdom, the United States, Kuwait, India, and Saudi Arabia. With state-of-the-art facilities and a wide range of medical specialties, including robotic orthopedics, bariatric surgery, transplants, cardiac interventions, and IVF, M42 sets the standard for premier medical care globally. By securing the GHA Medical Travel Patient Experience Certification, M42 now joins an elite group of certified medical tourism providers, further solidifying its position as a leader in the healthcare industry.

The UAE has emerged as a hub for medical tourism, with the market expected to grow significantly in the coming years. By 2027, the UAE’s medical tourism market is projected to reach US $273.72 billion, showcasing a substantial increase from US $104.68 billion in 2019. The country has welcomed around half a million medical tourists, with visitors from Asia, the Gulf region, and Europe comprising the largest groups.

Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42, expressed his pride in receiving the GHA Certification, stating, “M42 uniquely combines traditional health-tech and healthcare provision to address health holistically, not just healthcare. Receiving the first Global Healthcare Accreditation certification in the region reaffirms our commitment to the well-being and safety of those we serve. Our priority is people, not just patients, and this accreditation acknowledges not just our dedication to the people in our care, but also strengthens the UAE’s position as a premier destination for medical tourism.”

Renée-Marie Stephano, GHA’s Chief Executive Officer, commended M42 for achieving the Certification for Excellence in Medical Travel Patient Experience, highlighting the organization’s commitment to quality, safety, and patient-centered care. The GHA Certification process involves rigorous scrutiny of medical travel quality standards, ensuring that organizations meet the highest level of patient care throughout the entire patient journey.

As M42 continues to expand its global network and enhance its International Patient Services, the company aims to build strategic partnerships, develop health-tech solutions, and collaborate with international insurers to improve access to care for patients seeking medical treatment abroad. With a focus on growing the number of international medical tourists and generating economic returns, M42 remains dedicated to providing unparalleled health solutions to individuals worldwide.

In conclusion, M42’s achievement of the GHA Certification for Excellence in Medical Travel Patient Experience underscores the company’s commitment to delivering exceptional care and support to international patients, further solidifying its position as a leader in the global healthcare industry.